The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Chlordiazepoxide hydrochloride and clidinium bromide
Chlordiazepoxide hydrochloride and clidinium bromide · CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 · Capsule · Oral · Alembic Pharmaceuticals Limited
NDC 46708-0744-91 · 1000 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00187-4100-10) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$16.49per unit
middle half $0.2266–$48.55 · 18 plans · Jul 1, 2024
Est. net of rebatesⓘ
≈ $16.49
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
—of plans cover it
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 3 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for chlordiazepoxide hydrochloride and clidinium bromide (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA216969
- TE code
- AB
- Approval date
- Sep 15, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Chlordiazepoxide hydrochloride and clidinium bromide (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bausch Health US, LLC | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sunrise Pharmaceutical, Inc. | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Winder Laboratories LLC | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg/1; CLIDINIUM BROMIDE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Chlordiazepoxide hydrochloride and clidinium bromide — NDC 46708-0744-91," retrieved September 3, 2026, https://drugdashboards.com/drug/46708074491.
Free to cite with attribution — see how the data is put together.